At an estimated value of over USD 10.98 billion in 2019, the Global Acne Medication Market is predicted to thrive at a CAGR of 3.1% and valued at over USD 15.36 billion over the forecast year 2020-2030.
Acne is the most common skin conditions typically caused by changes in structures of the skin. It affects almost millions of adolescents around the globe. Hence, there is huge demand for topical as well as oral acne medication. Topical medication includes creams, gels, and ointments that consist of retinoids, benzoyl peroxide, salicylic acid, and others. On the other hand, oral acne medication is relatively more effective where moderate to severe acne do not respond to topical agents.Top Companies: Almirall SA., Bausch Health Companies Inc., Galderma S.A, Mayne Pharma Group Limited, GlaxoSmithKline Plc (GSK), Mylan N.V., Pfizer Inc., Johnson & Johnson, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd and others.
The global acne medication market share is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and geography. On the basis of therapeutic class, the market is categorized into retinoids, antibiotics, benzoyl peroxide, salicylic acid, and others. According to the formulation, the market is segmented into topical medications and oral medications. As per the type, the market is divided into prescription medicines and over-the-counter medicines. On the basis of acne type, the market is divided into non-inflammatory acne and inflammatory acne. As per the distribution channel, it is categorized as retail stores, e-commerce, and pharmacies & drug stores.In terms of geography, North America held major share of the market in 2019. This is attributed to the surge in use of skin care products and increased awareness about natural acne medication has propelled the demand for acne medication across this region. However, Asia-pacific is expected to grow rapidly with increasing market size due to the factors such as up surge in healthcare expenditure and higher demand for acne therapeutics across developing countries in the region.
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.